Fig. 7 | Scientific Reports

Fig. 7

From: Application of IVDr NMR spectroscopy to stratify Parkinson’s disease with absolute quantitation of blood serum metabolites and lipoproteins

Fig. 7

Metabolomic and lipoprotein alterations in the comparison of smaller groups (non-PD Controls, DLB, Mitochondrial diseases, PD double mutation carriers, PD LRRK2 positive, PD PRKN biallelic, and PD PRKN monoallelic). Using regression analysis (PLS-DA) 2-aminobutyrate (2-AB, shown as means ± SEM) and, on the other panel, LDL-3 and LDL-4 lipoprotein particles showed strong discriminatory power. PLS-DA – partial least squares discriminant analysis.

Back to article page